
- Telehealth visits
- Insurance plan information

Christopher Showers, MD
- Telehealth visits
- Insurance plan information



Christopher Showers, MD
- Telehealth visits
- Insurance plan information
On this page
Education & training
Board certification
- Nephrology, American Board of Internal Medicine/Nephrology
- Internal Medicine, American Board of Internal Medicine
Residency
- Internal Medicine, New York - Presbyterian Queens Hospital
Internship
- Internal Medicine, New York - Presbyterian Queens Hospital
Degree
- MD, American University of Antigua College of Medicine
Academic title
- Health Sciences Clinical Professor
Locations
My research
Publications
Showing 1-6 of 23 reviews
- August 26, 20265 out of 5 Stars
Dr Showers is such a kind doctor. He is very knowledgeable about my disease and always prepared when discussing my treatment. I always enjoy my visits with him and know that I am getting the best care.
- August 19, 20265 out of 5 Stars
WILL RECOMMEND DR. SHOWER TO ANY PERSON THAT MIGHT CARE FOR HYPERTENSION. AN EXTREMELY GREAT FIRST DAY EXPERIENCE IN COMPARISON TO ANY OTHER DOCTOR I EVER HAD. GREAT LISTENER
- August 15, 20265 out of 5 Stars
Excellent dialog and discussion
- August 13, 20265 out of 5 Stars
Dr Showers is a joy to work with.
- August 5, 20265 out of 5 Stars
Doctor Showers is taking over for retired physician Stephen Gluck and I was very apprehensive before the meeting but now I feel very confident he is going to be a great doctor as well.
- July 20, 20265 out of 5 Stars
I am lucky with my provider
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.